Intermediate doses of low-molecular-weight heparin for the long-term treatment of pregnancy thromboembolism. A systematic review

Thromb Haemost. 2014 Mar 3;111(3):559-61. doi: 10.1160/TH13-06-0510. Epub 2013 Dec 5.

Authors

E Gándara, M Carrier, M A Rodger¹

Affiliation

¹ Dr. Marc Rodger, Thrombosis Program, Ottawa Hospital-Ottawa Hospital Research Institute, General Campus-Centre for Practice Changing Research, 501 Smyth Road, Rm L2265e, Box 201A, Ottawa, Ontario K1H 8L6, Canada, Tel.: +1 613 737 8899 ext 79084, Fax: +1 613 739 6102, E-mail: mrodger@ohri.ca.

PMID: 24306093
DOI: 10.1160/TH13-06-0510

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Review
Systematic Review

MeSH terms

Anticoagulants / therapeutic use*
Drug Dosage Calculations
Female
Heparin, Low-Molecular-Weight / therapeutic use*
Humans
Pregnancy
Pregnancy Complications, Cardiovascular / drug therapy*
Time Factors
Venous Thromboembolism / drug therapy*

Substances

Anticoagulants
Heparin, Low-Molecular-Weight